Antigen Specific Humoral and Cellular Immunity Following SARS-CoV-2 Vaccination in ANCA-Associated Vasculitis Patients Receiving B-Cell Depleting Therapy

Overview of attention for article published in Frontiers in immunology, January 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

So far, Altmetric has seen 15 X posts from 14 X users, with an upper bound of 57,286 followers.

@PaigeMartyMD, #DrUlrichSpecks, #DrPatricioEscalante, @TobiasPeikertMD, and colleagues describe antigen specific humoral and cellular #immunity following #COVID19 #vaccination in #ANCA-associated #vasculitis patients receiving B-cell depleting therapy. htt

@PaigeMartyMD, #DrUlrichSpecks, #DrPatricioEscalante, @TobiasPeikertMD & colleagues suggest individuals on #Bcell depleting therapies should be vaccinated against #COVID19 following #Bcell recovery to elicit optimal #humoral and #cellular responses. ht

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 11 additional X posts.